However, the legal landscape for this peptide is complicated and full of red flags
The typical requirements for coverage are: FDA-approved medical condition: Ozempic is usually only covered as a treatment for certain conditions, such as: To improve blood sugar control in adults with type 2 diabetes To reduce the risk of stroke and heart attack in those with type 2 diabetes and established heart disease To reduce the risk of kidney function decline in those with type 2 diabetes and chronic kidney disease
That GnRH pulse then drives LH and FSH release from the pituitary, which in turn regulates ovulation and menstrual rhythm
Kidney Safety in Clinical Trials and Real-World Studies The SUSTAIN-6 trial, which followed over 3,000 patients with type 2 diabetes for nearly two years, documented that semaglutide significantly reduced the risk of new or worsening kidney disease compared to placebo
However, its important to monitor for nutrient deficiencies that may counteract these benefits
However, the body goes through many changes when taking this medicine
